Ahmed Mostafa MD, MSc, PhD, is Director (in training) of ASHI Certified Histocompatibility, Training Program Tissue Typing Laboratory, Department of Pathology, Laboratory Medicine Calgary, Laboratory Services & at University of Calgary. He is a Member of American Society for Histocompatibility and Immunogenetics (ASHI), Canadian Society for Immunology, Beatrice Hunter Cancer Research Institute, European Association of Cancer Research, American Association of Cancer Research, Canadian Society for Life Science Research, Tumor Microenvironment Working Group and American Society of Clinical Oncology.
Director Emeritus, Harvard Brain Tissue Resource Center, McLean Hospital William P. and Henry B. Test Professor of Psychiatry/Neuroscience, Harvard Medical School, United States.
Center for Nanotechnology and Tissue Engineer Photobiology and Photomedicine Research Group, Brazil
Center for Nanotechnology and Tissue Engineer Photobiology and Photomedicine Research Group,Department of Chemistry University of Sao Paulo (USP/FFCLRP), Brazil
Departmrnt of tissue engineering, Biomedical Engineering, Materials Engineering, Semnan University of Medical, Semnan, Iran
Researcher in Tissue Tech, Miami, FL, USA
Author(s): Omer Salah Mirghani Makawi*, Bassam Adil, Mohammed Daghash, Mohammed Al-Awad and Mohammed Shakeeb
Author(s): Anthony Davis
Author(s): Mahdi Saber Al-Deresawi1* , Abdul Hussein Moyet AlFaisal2 , and Aseel Razaq Al-Rekabi2
Author(s): Jochen Feldberg
Author(s): Maryam Mahdavi Afshar, Mohaddeseh Parsay, Meisam Gholami, Alex Avakian, Farid Salahshour Moghanloo, Mohammad Niatibozchelloei, Seyed Alireza Mousavi, Donya yousefi and Seyed Ali Hosseini Zavareh*
Author(s): The effects of cannabinoids are mediated by G-protein coupled cannabinoid receptors 1 (CB1) and 2 (CB2). CB1 is mainly present in the vascular and central nervous system whilst CB2 receptors are found within the immune tissues that are involved in immunomodulation. There is emerging evidence to suggest that the endocannabinoid system plays an important role in regulating the cardiovascular system. This review focuses on the therapeutic potential of Cannabidiol (CBD) on the cardiovascular system.